9p21 Locus Polymorphism Is A Strong Predictor of Metabolic Syndrome and Cardiometabolic Risk Phenotypes Regardless of Coronary Heart Disease.

Among all disease groups, a highly significant association ( p = 0.0003) of the rs1333049 variant was found with MetS/MetS-CHD − showing C allele carriers at a 4.04 times higher risk of MetS compared with non-carriers (OR = 4.04, 95% CI = 1.62–10.07).

also in 132,142 other papers